---
schema_version: "secwatch.filing_event.v1"
accession: "0001606498-25-000078"
form_type: "8-K"
ticker: "AVNS"
cik: "0001606498"
company_name: "AVANOS MEDICAL, INC."
filed_at: "2025-04-25T23:59:59+00:00"
generated_at: "2026-05-23T05:52:03.418577+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Avanos shareholders approve all proposals at 2025 annual meeting, including 2.25M share increase for LTIP

## Summary
- All five director nominees elected with 85.8% to 90.3% of votes cast; broker non-votes excluded.
- Deloitte & Touche ratified as auditor for 2025 with 94.7% of votes cast in favor.
- Say-on-pay advisory vote passed with 86.7% of votes cast for, 11.4% against.
- Amendment to 2021 Long Term Incentive Plan approved: 2,250,000 new shares added to reserve.
- 93.6% of outstanding shares represented at the meeting; high quorum.

## SEC filing metadata
- accession: 0001606498-25-000078
- form_type: 8-K
- ticker: AVNS
- cik: 0001606498
- company_name: AVANOS MEDICAL, INC.
- filed_at: 2025-04-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1606498/000160649825000078/0001606498-25-000078-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1606498/000160649825000078/avns-20250424.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001606498-25-000078
- JSON: https://secwatch.observer/filing/0001606498-25-000078.json
- Plain text: https://secwatch.observer/filing/0001606498-25-000078.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.